INDIANAPOLIS, May 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at the American Diabetes...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions )
Also on site :
- Owen and Luke Wilson Share Rare Red Carpet Moment at 'Stick' Premiere
- Pentagon employee arrested for trying to leak secrets over Trump grievances
- Horrific bus crash: 22 workers injured in Sadat City rollover